About this event
Genomics has already helped to elucidate the mechanisms of cancer evolution and metastasis. From the development of targeted therapies to diagnosis, genomics is also influencing clinical care.
However, genomics is not being utilised to its full potential. Join us for this 3-part virtual series where we will dissect current research that is shaping our understanding and guiding the next era of cancer therapeutics.
Tuesday 13th July, 3pm BST/ 4pm CET/ 10am EDT
This webinar will focus on the research that hunts to find oncogenes and traces tumour evolution in the hope to better understand, prevent, and treat cancer.
Measuring cancer evolutionary dynamics using genomics – Trevor Graham, Professor of Cancer Evolution, Barts Cancer Institute, QMUL
Genomic evolution of cancer models: perils and opportunities – Uri Ben-David, Assistant professor, Tel Aviv University
Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns – Fran Supek, Group Leader, Genome Data Science Laboratory, IRB Barcelona
Unravelling the inheritance of plastic states in cancer and beyond. One cell at a time – Maximiliano Portal, CRUK Institute Fellow, Cancer Research UK Manchester Institute
Tuesday 20th July, 3pm BST/ 4pm CET/ 10am EDT
Our understanding of the genetic basis and genomic evolution of cancer has already changed the way we approach cancer management. This webinar will focus on the clinical applications of cancer genomics.
Count Me In, partnering with patients to accelerate discoveries in cancer - Corrie Painter, Deputy Director, Count Me In, Broad Institute
Taking genomics to the clinic: Two TCGA examples – Jean Claude Zenklusen, Director, TCGA, NIH
Mutational signatures: from molecular mechanism to clinical application – Xueqing Zou, Postdoctoral fellow, University of Cambridge
Single cell multimodal and spatially resolved gene expression analysis to dissect the tumor and immune contexture - Hannes Arnold, Senior Science and Technology Advisor, 10x Genomics
Tuesday 27th July, 3pm BST/ 4pm CET/ 10am EDT
Manipulating the body’s natural immune system holds promise for alternatives to traditional surgery, chemotherapy, or radiotherapy in many situations.
This webinar will focus on the intersection of genomics and immunotherapy and highlight the opportunities for immunogenomics to influence cancer research and care.
Shared tumor antigens as immunotherapy targets: an in-silico investigation of the immunogenic potential of recurrent cancer drug-resistance mutations – Marco Punta, Immunogenomics lab coordinator, I.R.C.C.S. Ospedale San Raffaele
Clinical study design and considerations for genomics in Immuno-Oncology Drug Development – Maggie Cheang, Team Leader, Genomic Analysis of Clinical Trial, ICR
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events, reports, webinars and digital events, as well as operating a content-rich website.
Share this event